Brenda Zeitlin

PlantEXT Ltd. engages in the research, development, and commercialization of medical cannabis formulations for the treatment of inflammation related medical conditions. Its products include formulations for the prevention and treatment of symptoms of inflammatory bowel disease, pain, and psoriasis. The company was founded by Oded Sagee in 2015 and is headquartered in Toronto, Canada.

PlantEXT Ltd. engages in the research, development, and commercialization of medical cannabis formulations for the treatment of inflammation related medical conditions. Its products include formulations for the prevention and treatment of symptoms of inflammatory bowel disease, pain, and psoriasis. The company was founded by Oded Sagee in 2015 and is headquartered in Toronto, Canada.

PlantEXT Ltd. engages in the research, development, and commercialization of medical cannabis formulations for the treatment of inflammation related medical conditions. Its products include formulations for the prevention and treatment of symptoms of inflammatory bowel disease, pain, and psoriasis. The company was founded by Oded Sagee in 2015 and is headquartered in Toronto, Canada.

PlantEXT Ltd. engages in the research, development, and commercialization of medical cannabis formulations for the treatment of inflammation related medical conditions. Its products include formulations for the prevention and treatment of symptoms of inflammatory bowel disease, pain, and psoriasis. The company was founded by Oded Sagee in 2015 and is headquartered in Toronto, Canada.

PlantEXT Ltd. engages in the research, development, and commercialization of medical cannabis formulations for the treatment of inflammation related medical conditions. Its products include formulations for the prevention and treatment of symptoms of inflammatory bowel disease, pain, and psoriasis. The company was founded by Oded Sagee in 2015 and is headquartered in Toronto, Canada.